Sustainable Cold Mix Asphalt: A Comprehensive Review of Mechanical Innovations, Circular Economy Integration, Field Performance, and Decarbonization Pathways. [PDF]
Malik MD, Chen Y, Mu J, Dong R.
europepmc +1 more source
We found that plant species identity and soil properties, especially soil phosphorus availability, independently structured arbuscular mycorrhizal fungal (AMF) community composition in tropical forests across central Panama. We also found that soil nutrient availability may mediate the interaction networks between plants and AMF. ABSTRACT Plant species
Mareli Sánchez‐Juliá +3 more
wiley +1 more source
A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns. [PDF]
Yousuf M +14 more
europepmc +1 more source
ABSTRACT Real‐world data (RWD) offers a valuable opportunity to access vast information that can drive research and generate real‐world evidence (RWE), offering insights into the actual delivery of care and patient outcomes beyond the limitations of traditional clinical trials.
Katharine Cresswell +12 more
wiley +1 more source
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2. [PDF]
Espinoza-Gutarra MR +4 more
europepmc +1 more source
ABSTRACT A 66‐year‐old female presented with seven months of progressive right upper eyelid (RUL) drooping and thickening of her right lower eyelid (RLL). MRI revealed soft tissue enhancement of the RUL and RLL pre‐septal planes without posterior extension.
Grace L. Casado +4 more
wiley +1 more source
Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification. [PDF]
Sun J, Guo Z.
europepmc +1 more source
Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time? [PDF]
Atluri H, Abaza Y, Altman JK.
europepmc +1 more source
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort. [PDF]
Vetro C +22 more
europepmc +1 more source
Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation. [PDF]
Cheng J +6 more
europepmc +1 more source

